U. Nowak-Gottl, C. Wermes, R. Junker, H. G. Koch, R. Schobess, G. Fleischhack, D. Schwabe and S. Ehrenforth, “Prospective Evaluation of the Thrombotic Risk in Children with Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors,” Blood, Vol. 93, 1999, pp. 1595-1599.

has been cited by the following article:

• TITLE: Effect of Factor V Leiden on Thrombosis in Childhood Leukemia

  AUTHORS: Dilara Fatma Akın, Nejat Akar

  KEYWORDS: Thrombosis; Acute Leukemia; Childhood; Factor V Leiden

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.3 No.3, September 16, 2013

  ABSTRACT: Thromboembolism is an important complication in children undergoing therapy for ALL as it has the potential to impact adversely on both their survival and quality of life. The incidence of thrombosis in children with ALL varies between 1.1% and 36.7% and the actual mean is 3.2%. The aim of our study is to review the available reported data on the effect of FVL on thrombotic risk in pediatric patients with acute leukemia.